RECRUITING

Concept Elicitation and Patient Experience Mapping in SA-AKI

Talk to us

Conditions

Sepsis-associated Acute Kidney InjurySepsisAcute Kidney Injury

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a concept elicitation study on patient's experiences of Sepsis-associated Acute Kidney Injury (SA-AKI)

Official Title

Concept Elicitation and Patient Experience Mapping in Sepsis-associated Acute Kidney Injury

Quick Facts

Study Start:2025-05-01
Study Completion:2025-09-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07180238

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 85 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * ≥18 to ≤ 85 years of age
  2. * First diagnosis of SA-AKI at least 6 months prior to screening date, but no more than 10 years
  3. * Admitted due to sepsis and/or AKI to intensive care unit (ICU), intermediate care unit (IMCU), or high-dependency care unit, or developed sepsis and/or AKI during their inpatient hospital stay.
  4. * Resident of country of study (US or Germany)
  5. * Access to computer, tablet, or smartphone with internet connection
  6. * Willing to participate in an audio recorded interview
  7. * Copy of medical records (e.g., portable document format \[PDF\] file of electronic health record)
  8. * Physician confirmation of diagnosis of sepsis and AKI (post-sepsis)
  9. * ≥18 to ≤ 85 years of age
  10. * Primary caregiver/care-partner for eligible participant who experienced SA-AKI
  11. * Resident of country of study (US or Germany)
  12. * Access to computer, tablet, or smartphone with internet connection
  13. * Willing to participate in an audio recorded interview
  1. * Less than age of majority in locality (Participant is not considered an adult in their country or region)
  2. * Not willing to participate in an audio recorded interview
  3. * Not able to participate in the interview or complete required study surveys, based on the discretion of the study team

Contacts and Locations

Study Contact

Novartis Pharmaceuticals
CONTACT
1-888-669-6682
novartis.email@novartis.com
Novartis Pharmaceuticals
CONTACT

Principal Investigator

Novartis Pharmaceuticals
STUDY_DIRECTOR
Novartis Pharmaceuticals

Study Locations (Sites)

Novartis Investigative Site
East Hanover, New Jersey, 07936-1080
United States

Collaborators and Investigators

Sponsor: Novartis Pharmaceuticals

  • Novartis Pharmaceuticals, STUDY_DIRECTOR, Novartis Pharmaceuticals

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-05-01
Study Completion Date2025-09-30

Study Record Updates

Study Start Date2025-05-01
Study Completion Date2025-09-30

Terms related to this study

Keywords Provided by Researchers

  • Sepsis
  • Acute Kidney Injury

Additional Relevant MeSH Terms

  • Sepsis-associated Acute Kidney Injury